Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Contralateral recurrence of tumefactive demyelination.
[TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS].
Treatment of neuromyelitis optica.
[Treatment for multiple sclerosis in patients with collagen diseases].
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.
[Multiple sclerosis and pregnancy].
Genital and sexual pain in women.
The role of sphingosine 1-phosphate in immunity and sepsis.
Multiple Sclerosis treatment and infectious issues: Update 2013.
Relative contribution of cognitive and physical disability components to quality of life in MS.
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.
[The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis].
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
Poor responses to interferon-Beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis.
Neuroplasticity in Early Onset Multiple Sclerosis.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Diffuse astrocytoma arising within a demyelinating plaque.
Mechanisms of T2 * anisotropy and gradient echo myelin water imaging.
A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.
Natural antisense RNAs are involved in the regulation of CD45 expression in autoimmune diseases.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
A logically derived diet to stop MS relapses.
Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry.
Pages
« first
‹ previous
…
631
632
633
634
635
636
637
638
639
…
next ›
last »